What is Centessa Pharmaceuticals plc (CNTA)'s Q-Score?

StoQuant's Q-Score for CNTA is 34.0. The Q-Score is a composite rating from 0–100 that combines DCF valuation, earnings quality, competitive moat, analyst consensus, ML forecasts, and market sentiment.

Is CNTA stock undervalued according to StoQuant?

See the full StoQuant analysis to check whether CNTA is currently undervalued according to Graham intrinsic value estimates.

What is the CNTA stock forecast?

StoQuant's ML model generates a forecast for CNTA predicting the probability of outperformance vs. the S&P 500, updated daily. See the detailed forecast page for confidence intervals and named drivers.

Centessa Pharmaceuticals plc (CNTA) — AI-Powered Stock Analysis & Research

Analysis updated Jul 13, 2026 — scores and signals refreshed daily.

Centessa Pharmaceuticals plc (CNTA) stock research. Updated Jul 13, 2026. Q-Score 34/100 — Sell. Fair value, forecast, technicals, and insider activity.

Key Quantitative Facts

At-a-Glance Metrics

Sector: Health Care
Market Cap: $6.27B
Current Price: $40.50
52-Week Range: $22.09 – $40.50
Q-Score Verdict: Sell (34.0) grade D
Signal Coverage: 25 signals (20 alt-data)

Current Q-Score verdict: Sell (34.0) (grade D). 25 signals analyzed (20 differentiated alt-data).

How This Analysis Is Built

StoQuant's analysis of Centessa Pharmaceuticals plc (CNTA) is refreshed every trading day. The Q-Score combines discounted cash flow valuation, earnings quality, competitive moat, analyst consensus, ML return forecasts, technical momentum and market sentiment into a single 0–100 composite. Insider transactions from SEC Form 4 filings, the Graham intrinsic value estimate and signal coverage are recomputed as new data arrives, so this page always reflects the latest available information.

Recent Price Action & History

Trading Data & Technical Analysis

CNTA stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.

Peer Comparison in Health Care

Sector Peers & Valuation Comparison

How Centessa Pharmaceuticals plc stacks up against same-sector peers on market capitalization and alpha scores:

Ticker	Company	Market Cap	Alpha Score
BLCO	Bausch + Lomb Corporation	$5.8B	—
BLTE	Belite Bio, Inc	$5.7B	—
GRFS	Grifols, S.A.	$6.9B	33.0
LEGN	Legend Biotech Corporation	$5.2B	—
STVN	Stevanato Group S.p.A.	$4.8B	—

Explore Sector Analysis

View all Health Care stocks by valuation and signals →

Key Analysis Points for Centessa Pharmaceuticals plc

What Drove CNTA's Score

Centessa Pharmaceuticals plc (CNTA) scores Sell (34.0), with every measured dimension at or below 44. The weakest are technicals at 40, across 2 measured dimensions. See Q-Score methodology for how these dimensions are weighted and combined.

Q-Score dimensions, normalized 0-100
Dimension	Score
analyst consensus	44
technicals	40

Signal Diversity

StoQuant analyzes 25 signals (20 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.

What StoQuant Measures for CNTA

Core Signals & Metrics

AI Alpha (Gem) Score: Combines 15+ technical signals (momentum, RSI, moving averages) with fundamentals (earnings surprise, growth consistency) and sentiment. 0–100 scale, residualized by sector so peer-relative strength is visible.
Benjamin Graham Intrinsic Value: DCF-based valuation using conservative earnings assumptions and sector-median discount rates. Margin of safety measures distance from intrinsic value to current price.
Composite Q-Score: Blends DCF upside potential, earnings quality (Piotroski F-Score, Altman Z-Score for distress risk), competitive moat score, analyst consensus, and social/news sentiment into one 0–100 verdict.
ML Price Forecasts: Probability estimates using historical price/volume patterns.
Insider & Institutional Flow: Officer and large shareholder transactions from SEC filings (10-K, Form 4), concentration analysis, and transaction patterns over 14/90-day windows. See insider activity methodology.
Sector & Macro Context: Market regime classification (bull/bear/correction), sector rotation, and portfolio context. Same stock signal reads differently across market environments.

Learn StoQuant's Signals & Scoring

Knowledge Base & Methodology

All StoQuant signals are explained in our knowledge base:

Q-Score Methodology — How StoQuant combines dimensions: DCF, earnings quality, moat, analyst consensus, ML, sentiment
Portfolio Construction — Building balanced portfolios with StoQuant signals
Diversification & Correlation — Cross-sector allocation and risk-adjusted returns

Compare & Research Tools

Direct Comparisons

CNTA vs BLCO — comparison
CNTA vs BLTE — comparison
CNTA vs GRFS — comparison
CNTA vs LEGN — comparison
CNTA vs STVN — comparison
CNTA vs ABVX — comparison
CNTA vs MANE — comparison
CNTA vs ICLR — comparison
CNTA vs HNGE — comparison
CNTA vs NAMS — comparison
CNTA vs KNSA — comparison
CNTA vs BLLN — comparison

Broader Research Tools

Stock Screener — Filter 3,600+ stocks by Q-Score, alpha, Graham value, insider flow
ML Stock Forecast — Return probability forecast with confidence intervals and driver analysis
Full Stock Screener — Filter 3,600+ tickers by metrics, find outliers in any category

Sector-Specific Research

Health Care Hub — Top performers and valuation outliers in Health Care

Free Daily Digest: CNTA in Your Inbox

Curated Signals for Your Watchlist

Get daily updates on Centessa Pharmaceuticals plc (CNTA): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.

Subscribe Now

Browse daily research picks • Unsubscribe anytime • Privacy policy

About StoQuant

Platform Overview

StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and IC-weighted signals (live edge on /proof). We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.

Embed & Share

Share CNTA Q-Score Badge

Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:

<a href="https://stoquant.com/research/CNTA"><img src="https://stoquant.com/badge/CNTA.svg" alt="Centessa Pharmaceuticals plc (CNTA) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>

Disclaimer & Methodology

How StoQuant Works

StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.

Learn More

Full methodology • Terms of use • Contact us.